Loading clinical trials...
Loading clinical trials...
The purpose of this study is to see if repeat bacillus Calmette-Guérin (BCG) vaccinations can confer a beneficial immune and metabolic effect on Type 1 diabetes. Published Phase I data on repeat BCG v...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Massachusetts General Hospital
NCT07011147 · Type 1 Diabetes (T1D), Type 2 Diabetes, and more
NCT06688331 · Presymptomatic Diabetes Type 1 (Stage 1), Diabetes Mellitus, Type I, and more
NCT05180591 · Diabetes Mellitus, Type 1, Diabetes type1, and more
NCT06967701 · Type 1 Diabetes (T1D), Latent Autoimmune Diabetes in Adult (LADA), and more
NCT06860516 · Diabetes Mellitus, Type I
Immunobiology Labs CNY 149
Charlestown, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions